BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A; Baveno Cooperation: an EASL consortium. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. J Hepatol 2023:S0168-8278(23)00112-5. [PMID: 36858157 DOI: 10.1016/j.jhep.2023.02.023] [Reference Citation Analysis]
2 Misbahuddin-Leis M, Ademi B, Ankolvi M, Dubasz K, Mishra M, Riechmann M, Graeb C, Radeleff B. Successful heparin-perfusion therapy for complete thrombosis of the intra- and extrahepatic portal and mesenteric vein. A case report and literature review. Radiol Case Rep 2023;18:850-5. [PMID: 36589499 DOI: 10.1016/j.radcr.2022.11.052] [Reference Citation Analysis]
3 Odriozola A, Puente Á, Cuadrado A, Rivas C, Anton Á, González FJ, Pellón R, Fábrega E, Crespo J, Fortea JI. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. JCM 2022;11:6435. [DOI: 10.3390/jcm11216435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]